CClinicalTrials.gg
CompletedNCT03572894RPVIUpdated Dec 5, 2018

Comparison of PVI and RPVI

An observational study in Venous; Return (Anomaly), sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-05.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
35
Ages
18 Years and older
Sex
All
01

Study summary

Pleth Variability Index (PVI) is a non-invasive and automated measure of the respiratory variations of plethysmography during mechanical ventilation. PVI is extracted via an algorithm implemented on Masimo Radical 7 device (Masimo, Irvine, CA). PVI is commonly used in anesthesiology and has been validated to predict fluid responsiveness and optimize fluid administration in the surgical setting. However, the signal/noise ratio of PVI makes acute changes in PVI somewhat difficult to interpret at the bedside. Subsequently, a new algorithm entitled RPVI (Rainbow Pleth Variability Index), has been developed in order to improve the signal/noise ratio of PVI and facilitate its clinical use by practitioners. The details of this new proprietary built-in algorithm are unknown and no data are available to date. Therefore, the main objective of the study was to compare RPVI and PVI during dynamic changes in venous return induced by a tidal volume (Vt) challenge during mechanical ventilation in anesthetized patients. The hypothesis was that the agreement between both dynamic indices would be good.

02

Conditions studied

  • Venous; Return (Anomaly)
03

In context

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All adult patients undergoing closed-chest surgery in the supine position under general anaesthesia.

Inclusion criteria

  • Age > 18
  • Low or intermediate risk surgery or noninvasive procedures in the supine position
  • General anaesthesia and volume-controlled mechanical ventilation.

Exclusion criteria

Exclusion Criteria:

  • Non sinus heart rhythm
  • Left Ventricular Ejection Fraction \< 50%
  • Documented right ventricle failure
  • Lack of patient consent
  • Pregnancy
  • Minor patient or under tutorship
  • Presence of spontaneous ventilatory movements (attested by a real respiratory rate higher than the set respiratory rate)
  • Report HR / RR \<3.6 (HR: heart rate, RR: respiratory rate)
  • Open chest surgery
  • Laparoscopic surgery
  • Vital or lateral decubitus surgery
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
35 participants (actual)
Patient registry
No

Interventions

  • DevicePVI and RPVI measurements

    PVI and RPVI measurements during variations of the tidal volume (Vt challenge) and a recruitment maneuver in anesthetized and mechanically ventilated patients. * T0 : Vt 6 mL/kg of predicted body weight (PBW) during 5 minutes * T1 : Vt 8 mL/Kg of PBW during 5 minutes * T2 : Vt 10 mL/kg of PBW during 5 minutes * T3 : Vt 6 mL/kg of PBW during 5 minutes * T4 : A single recruitment maneuver Data will be recorded at each step.

06

What researchers measure

Primary outcomes

  1. Evaluation of the diagnostic characteristics of RPVI in comparison to PVI

    Agreement and interchangeability of RPVI and PVI: Bland Altman analysis for repeated measurements

    Time frame: 30 minutes

07

Study locations

1 site
  • Service d'Anesthésie Réanimation, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon
    Bron, 69394, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03572894
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Jun 28, 2018
Start date
Jul 25, 2018
Primary completion
Sep 27, 2018
Completion
Sep 27, 2018
Last update
Dec 5, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion